Literature DB >> 19180796

Enhanced cytokine synthesis of leukocytes by a beta-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa.

Sachiko Nameda1, Toshie Harada, Noriko N Miura, Yoshiyuki Adachi, Toshiro Yadomae, Mitsuhiro Nakajima, Naohito Ohno.   

Abstract

Sparassis crispa is edible mushroom recently cultivable in Japan. It contains significantly high content (approximately 40%) of 6-branched 1,3-beta-D-glucan showing antitumor activity in mice. We recently purified a beta-glucan preparation designated as "SCG." It was considered worth while to test SCG in vitro with whole blood collected from human volunteers. The present study is focusing on the cytokine productivity of SCG in an in vitro human system. The following results were observed: (i) SCG dose dependently enhanced IL-8 synthesis of whole blood cell culture of human peripheral blood. (ii) IL-8 synthesis was enhanced in both PBMC and PMN cultures. (iii) IL-8 synthesis was induced in the culture with autologous plasma, but significantly reduced after 56 degrees C treatment. (iv) The activity was also weak in heat inactivated fetal calf serum (FCS). (v) A complement fragment, C5a, was released by SCG dependently upon dose and kinetics. (vi) Anti-SCG natural antibody was detected in human plasma. From these facts, SCG was observed to have the capacity to activate human leukocytes and related immune system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 19180796     DOI: 10.1081/iph-120024500

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  8 in total

Review 1.  Medicinal, nutritional, and nutraceutical potential of Sparassis crispa s. lat.: a review.

Authors:  Neha Sharma; Ashwani Tapwal; Rachna Verma; Dinesh Kumar; Eugenie Nepovimova; Kamil Kuca
Journal:  IMA Fungus       Date:  2022-05-06       Impact factor: 8.044

2.  Agrobacterium sp.-derived β-1,3-glucan enhances natural killer cell activity in healthy adults: a randomized, double-blind, placebo-controlled, parallel-group study.

Authors:  Yeon Joo Lee; Doo-Jin Paik; Dae Young Kwon; Hye Jeong Yang; Yongsoon Park
Journal:  Nutr Res Pract       Date:  2017-01-24       Impact factor: 1.926

Review 3.  Potential of Mushroom Compounds as Immunomodulators in Cancer Immunotherapy: A Review.

Authors:  Peter Amwoga Ayeka
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-22       Impact factor: 2.629

4.  Sparassis crispa Intake Improves the Reduced Lipopolysaccharide-Induced TNF-α Production That Occurs upon Exhaustive Exercise in Mice.

Authors:  Masataka Uchida; Naoki Horii; Natsuki Hasegawa; Eri Oyanagi; Hiromi Yano; Motoyuki Iemitsu
Journal:  Nutrients       Date:  2019-09-02       Impact factor: 5.717

Review 5.  Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa.

Authors:  Takashi Kimura
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

6.  Generation and Evaluation of High β-Glucan Producing Mutant Strains of Sparassis crispa.

Authors:  Seung-Rak Kim; Hyeon-Woo Kang; Hyeon-Su Ro
Journal:  Mycobiology       Date:  2013-09-30       Impact factor: 1.858

7.  Mitochondria Related Pathway Is Essential for Polysaccharides Purified from Sparassis crispa Mediated Neuro-Protection against Glutamate-Induced Toxicity in Differentiated PC12 Cells.

Authors:  Shuang Hu; Di Wang; Junrong Zhang; Mengyan Du; Yingkun Cheng; Yan Liu; Ning Zhang; Di Wang; Yi Wu
Journal:  Int J Mol Sci       Date:  2016-01-26       Impact factor: 5.923

Review 8.  Effects of Sparassis crispa in Medical Therapeutics: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Le Thi Nhu Ngoc; You-Kwan Oh; Young-Jong Lee; Young-Chul Lee
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.